Bio Protocol vs Cetus Protocol — how do they compare? Bio Protocol trades at Rp440.27 (market cap Rp996,68M, Rp165,43M 24h volume), while Cetus Protocol trades at Rp348.33 (market cap Rp334,27M, Rp35,4M 24h volume). The key difference: Bio Protocol is far larger — about 3× Cetus Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 960,9M / 1B CETUS (97%) for Cetus Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Cetus Protocol for 31 Days on average.
| BIO | CETUS | |
|---|---|---|
Market Cap | Rp996,68M | Rp334,27M |
Volume (24h) | Rp165,43M | Rp35,4M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 960,9M / 1B CETUS (97%) |
Typical Hold Time | 18 Days | 31 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Cetus Protocol is trading at Rp348.22 with a market cap of Rp336.03M, showing bullish technical signals with strong moving average support. The token is near full circulation at 97% with relatively short 31-day average hold time. Current price sits at the pivot point of Rp348, with resistance at Rp354 and support at Rp344. Technical indicators show mixed signals with overbought RSI readings but strong ADX trend strength.
Overall outlook remains cautiously bullish with strong technical momentum but overbought conditions suggest potential near-term consolidation. Key opportunities include the high circulation rate and strong trend indicators, while risks include overbought RSI levels and typical crypto volatility. Investors should monitor support levels closely for entry opportunities.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Cetus Protocol, a decentralized exchange and liquidity protocol, operates on the Sui and Aptos blockchains. It leverages the Concentrated Liquidity Market Makers (CLMM) paradigm, integrating elements from Uniswap V3 and Trader Joe to offer advanced trading and liquidity options. Cetus aims to build a robust and flexible liquidity network, enhancing trading experiences and liquidity efficiency for DeFi users.
Read more on CETUS →